In vitro and in vivo studies have demonstrated that OSI-930 can inhibit c-Kit activity and downstream signaling pathways, leading to inhibition of cancer cell proliferation and induction of apoptosis (Garton et al., 2006). This evidence concerns the gene KIT and cancer.